Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Hiba Salih"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of the Pakistan Medical Association; 2024 Supplement, Vol. 74, pS-290-S-293, 4p
Publikováno v:
Journal of the Pakistan Medical Association; 2024 Supplement, Vol. 74, pS-287-S-289, 3p
Autor:
Salih, Hiba Salih Hussein
Grafen; malzeme, malzeme bilimi ve yoğun madde fiziğinin ufukta hızla yükselen bir yıldızıdır. Kısa geçmişinde, fizik ve potansiyel uygulama çeşitliliği göstermekle birlikte, iki boyutlu bu malzeme olağanüstü yüksek kristal ve elek
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10208::cbdbfce665fccf32302bbc1122dc5b02
https://acikbilim.yok.gov.tr/handle/20.500.12812/474182
https://acikbilim.yok.gov.tr/handle/20.500.12812/474182
Autor:
Heidi De Smedt, Hiba Salih, Eef Hoeben, Peter de Boer, Ion Anghelescu, Luc Van Nueten, I. Kezic, Vikash K. Sinha
Publikováno v:
Journal of Psychopharmacology. 29:414-425
Metabotropic glutamate receptor-2 positive allosteric modulator, JNJ-40411813 (ADX71149), was characterised for clinical effects in healthy volunteers in two phase-1 studies. In study 1, healthy men received 50-, 100-, 150- or 225 mg and women receiv
Autor:
Richard M. W. Hoetelmans, Romana Petrovic, Tom Van De Casteele, Magda Opsomer, Mark Neujens, Thomas N. Kakuda, Hiba Salih
Publikováno v:
Antiviral therapy. 19(6)
Background Darunavir requires pharmacokinetic enhancement to increase its bioavailability. Cobicistat is potentially an alternative pharmacokinetic booster to ritonavir. Bioequivalence of a darunavir/cobicistat fixed-dose combination (FDC) versus dar
Autor:
Kenneth C. Turner, Seema Vaidyanathan, Jay Ariyawansa, Jaya Natarajan, Kenneth Todd Moore, Hiba Salih, William M. Byra
Publikováno v:
British Journal of Clinical Pharmacology
Aims The primary objective was to explore the pharmacodynamic changes during transition from rivaroxaban to warfarin in healthy subjects. Safety, tolerability and pharmacokinetics were assessed as secondary objectives. Methods An open label, non-rand
Publikováno v:
Psychopharmacology. 229(1)
Smoking withdrawal has been widely established to produce a range of impairments to the quality of several major domains of cognitive function including attention, working memory and episodic memory. This study was conducted to determine the degree t
Autor:
Mahdi Al-Khassaki HS; Department of Physiology, Mustansiriyah University. Baghdad, Iraq., Al-Galani BT; Department of Physiology, Mustansiriyah University. Baghdad, Iraq.
Publikováno v:
JPMA. The Journal of the Pakistan Medical Association [J Pak Med Assoc] 2024 Oct; Vol. 74 (10 (Supple-8)), pp. S287-S289.